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Background and aims: Tubulointerstitial fibrosis represents the key underlying pathology in diabetic 
kidney disease and is characterised by tubular injury and extracellular matrix remodelling. In diabetic 
nephropathy increased collagen I deposition is linked to inflammation and fibrosis, yet, we know little as 
to how collagen facilitates these effects. Pivotal to early tubular injury is impaired epithelial (E)-cadherin 
mediated cell adhesion; loss of which inhibits docking of connexin-mediated hemichannels and prevents 
gap junction intercellular communication. Uncoupled hemi-channels respond via increased release of 
adenosine triphosphate (ATP), an effect we have previously confirmed is linked to increased expression 
of inflammatory and fibrotic markers. The current study investigates if collagen I mediates its effects 
through altered connexin-43 (Cx43) mediated hemichannel activity in human proximal tubule cells. 
Materials and methods: Human kidney (HK-2) proximal tubule cells were cultured on collagen I 
(50μg/mL) and treated for 48 hours ± TGF-β1 (2-10ng/mL). Uncoated plastic served as the control. 
Expression of candidate proteins was determined by immunoblotting. Cell-substrate interactions were 
measured using the Cytoselect cell adhesion assay. Carboxyfluorescein (200μM) dye uptake and ATP 
biosensing were used to measure hemichannel activity and ATP release respectively in TGF-β1 treated 
HK-2 at 48 hours. 
Results: Immunoblot analysis confirmed that TGF-β1 increased collagen I expression to 167±19%, 
181±8% and 192±19% at 2, 4 and 10ng/mL respectively as compared to control, whilst adhesion assays 
confirmed that HK-2 cells exhibit increased affinity for collagen I in the presence of TGF-β1 (10ng/mL) 
to 0.36±0.06OD as compared to control (0.15±0.02OD) (n=4, P<0.05). Interestingly, when cultured on 
collagen I, cells exhibit increased expression of Cx43 to 107±16%, with co-incubation of TGF-β1 
exacerbating this effect to 136±7% as compared to control (n=5, P<0.001). This increase in expression 
was paralleled by increased hemichannel activity and ATP release. Carboxyfluorescein dye uptake 
increased in cells cultured on collagen I ± TGF-β1 to 149±6% (collagen I) and 251±5% (collagen I + 
TGF-β1) respectively, as compared to control (n=5, P<0.001), whilst biosensing confirmed a significant 
increase in ATP, increased from 2.2±0.4μM (collagen I) to 4.5±0.2μM (collagen I + TGF-β1) as 
compared to control (n=3, P<0.001). 
Conclusion: The current study confirms a role for collagen I in regulating connexin-43 expression, 
changes which are exacerbated in the presence of pro-fibrotic TGF-β1, the principal mediator of damage 
in the tubular region of the diabetic kidney. Increased expression of this protein, central to cell-cell 
communication, was paralleled by increased hemichannel mediated ATP release, most likely a 
consequence of diminished cell-cell adhesion and gap junction mediated intercellular communication as 
previously reported by the group. With studies linking increased collagen I deposition to altered cell 
phenotype in tubulointerstitial fibrosis, and elevated ATP release to increased fibrosis and inflammation; 
this study highlights a potential role for collagen I in exacerbating diabetic tubular injury by regulating 
connexin-mediated hemichannel activity. 
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